Univ Health Svc Stock Price, News & Analysis

Universal Health Services (NYSE: UHS) will release fourth-quarter 2025 results for the period ended December 31, 2025, after market close on Wednesday, February 25, 2026. A conference call for investors and analysts is scheduled at 9:00 a.m. ET on Thursday, February 26, 2026.

A live webcast will be available on the company's website and telephone participation requires advance registration; a replay will be available for one year.

Acadia Healthcare (NASDAQ: ACHC) appointed Debra K. Osteen as Chief Executive Officer and added her to the Board, effective immediately, with Chris Hunter departing the company and its Board. The Board said it will conduct a comprehensive search for a long-term successor while Osteen leads the company. The company reaffirms its full-year 2025 guidance, expecting revenue $3.28B–$3.30B, Adjusted EBITDA $601M–$611M, and adjusted EPS $1.94–$2.04. Management previously reiterated guidance at the J.P. Morgan Healthcare Conference on January 13, 2026. The company noted it cannot reconcile projected Adjusted EBITDA and adjusted EPS to GAAP due to unknown transaction-related expenses and their tax effects.

Universal Health Services (NYSE: UHS) announced its Board of Directors approved a cash dividend of $0.20 per share. The dividend is payable on December 15, 2025 to shareholders of record as of December 1, 2025.

UHS operates acute care hospitals, behavioral health facilities, outpatient centers and ambulatory access points across the United States, Puerto Rico and the United Kingdom.

Universal Health Services (NYSE: UHS) will present at the Wolfe Research Healthcare Conference 2025 in New York on Wednesday, November 19, 2025 at 8:00 a.m. EST.

A live audio webcast and a replay will be available via the company’s Investor Relations website at www.uhsinc.com. Universal Health Services operates acute care hospitals, behavioral health facilities and ambulatory centers across the United States, the United Kingdom, and Puerto Rico.

Universal Health Services (NYSE: UHS) reported strong third-quarter 2025 results and raised full-year guidance on October 27, 2025. Q3 net income attributable to UHS was $373.0 million ($5.86 diluted) and net revenues rose 13.4% to $4.495 billion. Adjusted Q3 EBITDA net of NCI was $670.6 million. For the first nine months, net income was $1.043 billion and net revenues were $12.879 billion, up 9.9% year-over-year. The Board authorized a $1.5 billion increase to the stock repurchase program, bringing available authorization to $1.759 billion.

The company raised its 2025 revised forecast to $17.306–$17.445B net revenues and Adjusted EPS $21.50–$22.10, citing operating trends and a new Washington, D.C. Medicaid payment program.

Universal Health Services (NYSE: UHS) will report third-quarter results for the period ended September 30, 2025 after the market close on Monday, October 27, 2025. A conference call for investors and analysts is scheduled for 9:00 a.m. ET on Tuesday, October 28, 2025 and will be accessible via a live webcast on the company's website at www.uhs.com. Telephone participation requires advance registration; registrants receive a confirmation email with dial-in details, a unique passcode, and registrant ID. A replay of the call will be available for one year following the live event. The company operates acute care hospitals, behavioral health facilities and ambulatory centers across the United States, the United Kingdom, and Puerto Rico.

Universal Health Services (NYSE: UHS), a leading healthcare services provider, has appointed Darren Lehrich as Vice President of Investor Relations, reporting to CFO Steve Filton. Lehrich brings extensive experience from his previous roles, including CFO at Help at Home and investor relations leadership positions at Magellan Health and American Renal Associates.

Prior to his corporate roles, Lehrich spent 17 years as an equity research analyst, including serving as managing director at Deutsche Bank from 2005-2015. He holds a Bachelor's degree in Health Policy and Administration from Penn State and an MBA in Finance from Purdue University.

Universal Health Services (NYSE:UHS), one of the nation's largest healthcare providers, announced upcoming presentations at two major healthcare conferences. Steve Filton, Executive Vice President and CFO, will present at the 2025 Wells Fargo Healthcare Conference in Boston on September 5 at 10:15am ET and at Baird's 2025 Global Healthcare Conference in New York on September 10 at 9:05am ET.

Live audio webcasts will be available on the company's website, with replays accessible for 90 days following the conferences. UHS operates acute care hospitals, behavioral health facilities, outpatient facilities, and ambulatory care access points across the United States, Puerto Rico, and the United Kingdom.

Universal Health Services (NYSE:UHS) reported strong Q2 2025 financial results and raised its full-year guidance. Net income reached $353.2 million ($5.43 per diluted share), up from $289.2 million in Q2 2024. Net revenues increased 9.6% to $4.284 billion.

The company benefited from $101 million in incremental Medicaid reimbursements, including $58 million from Tennessee's new directed payment program. However, UHS incurred a $25 million pre-tax loss from a newly opened hospital in Washington, D.C.

Based on strong H1 2025 performance, UHS increased its 2025 forecast, projecting net revenues of $17.096-17.312 billion and adjusted EPS of $20.00-21.00. The company continued its stock buyback program, repurchasing 875,000 shares for approximately $150.8 million in Q2 2025.